Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,746 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05127148Recruiting
Real-world study of pediatric-like treatment for Ph-negative ALL
This study follows how well a “pediatric-style” treatment plan works in teens and young adults with Ph-negative acute lymphoblastic leukemia (ALL) in real-world care. It mainly aims to understand outcomes and safety for patients who fit the specific leukemia and health criteria.
Paraná, Entre Ríos ProvinceAges 18–40 - NCT06191549Recruiting
Brain stimulation to improve walking after stroke
This study tests whether a non-invasive brain stimulation treatment can help improve walking ability in people who have had a stroke. It compares the effects of the treatment in stroke survivors and healthy adults to see if it can enhance recovery.
Galveston, TexasAges 21–90 - NCT07860216RecruitingPhase 3
RSV vaccine safety and immune response study for older adults
This trial tests an experimental vaccine to protect older adults against respiratory syncytial virus (RSV), a common virus that can cause serious lung infections. It looks at whether the vaccine is safe and how well it boosts immunity. If you are healthy and over 60, you might be able to join.
GuiZhou, GuizhouAges 60 years+ - NCT07856927Recruiting
Support group for caregivers of autistic young adults
This study tests a group intervention to help family caregivers of autistic young adults (ages 18-26) navigate disclosure and stigma. If you are a primary caregiver, you may find support and strategies to handle these challenges.
Madison, WisconsinAges Any age - NCT01913938Recruiting
Testing treatment for severe inflammation in very ill adults
This trial looks at how to treat a severe, whole-body immune overreaction (“hemophagocytosis”) in adults who are critically ill. You might be considered if blood counts are low (white blood cells and platelets) and if you are already receiving a growth-factor medicine (rhG-CSF).
UlmAges 18–90 - NCT05969041RecruitingPhase 1
Early-phase drug trial for advanced epithelial cancers
This Phase 1 study tests a new drug (MT-302) in adults with advanced or metastatic epithelial cancers that have worsened or stopped responding to standard treatment. The goal is to see how the drug works and whether it is safe for people with limited options.
Darlinghurst, New South WalesAges 18 years+ - NCT06220487RecruitingPhase 2
New drug combo for Ph+ ALL without transplant
This trial tests a combination of three drugs—olverembatinib, a bispecific T-cell engager, and chidamide—for adults newly diagnosed with Ph+ ALL who cannot have a stem cell transplant. The goal is to see if this treatment works well without needing intensive chemotherapy.
Guangzhou, GuangdongAges 18 years+ - NCT07855939Recruiting
Iron absorption and loss in women over time
This study looks at how well women absorb iron and lose it over a long period. It compares normal-weight women with overweight or obese women who have low-level inflammation. The goal is to understand iron levels in the body, which could help improve iron recommendations.
Nakhon PathomAges 40–50 - NCT07853898Recruiting
Pistachio snack trial for young adults with overweight
This study looks at how eating pistachios affects blood sugar and appetite after meals in young adults with overweight or obesity. Participants will eat pistachio snacks or a refined-carb snack and have blood tests to compare the effects.
St Louis, MissouriAges 18–35 - NCT07855874Recruiting
Voice assistant for healthy aging at home
This study tests a voice-based assistant that helps older adults live well at home. It may help you stay independent and engaged.
TaipeiAges 55–100 - NCT07855484Enrolling by invitation
Improving end-of-life talks between doctors and young adults with cancer
This study helps young adults with advanced cancer talk with their doctors about what matters most for their care and future. It aims to make these conversations easier and more helpful for patients and families.
Basking Ridge, New JerseyAges 18–39 - NCT05695638Recruiting
Genetic tumor testing to find treatments for advanced cancer
This study looks at your tumor’s genetic information to help match you to targeted treatments when standard options are no longer working. You may be offered options based on results, with the goal of helping people with incurable, worsening cancer.
AalborgAges 18 years+ - NCT06237192Recruiting
Treatment for adults with Ph-negative ALL
This trial tests a less intensive but continuous treatment approach for adults newly diagnosed with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to improve outcomes by using minimal residual disease (MRD) to guide therapy.
MoscowAges 18–55 - NCT06246071RecruitingPhase 1
TYK-00540 for adults with solid tumors
This trial tests a new drug, TYK-00540, for people with solid tumors that have not responded to or cannot tolerate standard treatments. It also looks at specific types of breast and ovarian cancer.
HefeiAges 18 years+ - NCT04282044RecruitingPhase 1
CRX100 drug trial for advanced cancers with or without pembrolizumab
This Phase 1 trial tests CRX100 (a new cancer medicine) alone and with pembrolizumab (an immune checkpoint drug) in people with advanced solid tumors. It’s mainly designed to check safety and side effects, and to see whether tumors respond, potentially helping people whose cancer has come back or stopped responding to standard treatment.
Scottsdale, ArizonaAges 18 years+ - NCT07861893Enrolling by invitation
Heart health study for active Saudi women
This study looks at how regular exercise affects heart structure and function in healthy Saudi women. It aims to understand normal heart changes in active women to better guide health care.
DammamAges 18–45 - NCT07866118Recruiting
Immune recovery treatment for adults with sepsis
This study tests a medicine called thymalfasin, which may help the immune system recover in adults with sepsis (a severe infection that causes organ damage). It aims to see if this treatment can improve immune function and possibly outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06103929Recruiting
Adult eating disorder assessment study
This study aims to improve how eating disorders are assessed in adults. It will test a new assessment tool (called SCAN) to see if it works well for people who have been referred to specialist eating disorder services.
LeicesterAges 16 years+ - NCT05638724Recruiting
Long COVID health registry for people of all ages
This study builds a health registry to learn how long COVID affects children, teens, and adults over time. It may help by improving understanding of symptoms and care, even if it does not test a new drug.
Munich, BavariaAges Any age - NCT07871513RecruitingPhase 2
Facial line treatment with two botulinum toxins
This study tests a new combination of two botulinum toxin types (trenibotulinumtoxinE and onabotulinumtoxinA, commonly known as Botox) for treating moderate to severe frown lines between the eyebrows. It aims to see if the combination is safe and works well.
Glendale, ArizonaAges 18 years+ - NCT07873151Enrolling by invitation
Voice-activated call light for limited arm mobility
This study tests a voice-activated call light system that lets people with limited arm movement call for help by speaking. It aims to make it easier and safer for clients to get assistance.
Omaha, NebraskaAges 19 years+ - NCT07859280Recruiting
Vitamin D in eggs for healthy adults
This study tests whether eating eggs enriched with vitamin D can help raise vitamin D levels in healthy adults. If it works, it could be a simple way to improve vitamin D without supplements.
Ithaca, New YorkAges 18–40 - NCT07870525Recruiting
Chest x-ray vs low-dose CT in emergency department
This trial compares two types of chest imaging for adults in the emergency department who might have community-acquired pneumonia (CAP). It helps find out if a low-dose CT scan is better than a regular chest x-ray for diagnosing this condition.
AabenraaAges 18 years+ - NCT06271083Recruiting
Online behavior therapy for Tourette syndrome in adults
This trial tests an online behavior therapy program for adults with Tourette syndrome or chronic tic disorder. You'll complete a 10-week internet-based treatment from home, with therapist support, to help reduce your tics.
StockholmAges 18 years+
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,746 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.